Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain
- 1 October 1995
- journal article
- case report
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 10 (7), 564-568
- https://doi.org/10.1016/0885-3924(95)00102-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at homeJournal of Pain and Symptom Management, 1994
- Response of chronic neuropathic pain syndromes to ketamine: a preliminary studyPain, 1994
- Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidencePain, 1993
- Comparison of the Antinociceptive Effects of Pre- and Posttreatment with Intrathecal Morphine and MK801, an NMDA Antagonist, on the Formalin Test in the RatAnesthesiology, 1992
- Opioid sensitivity of chronic pain: a patient‐controlled analgesia methodAnaesthesia, 1992
- Predictive factors in advanced cancer pain treated only by analgesicsPain, 1992
- The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsPain, 1990
- Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the ratBrain Research, 1990
- The Edmonton staging system for cancer pain: preliminary reportPain, 1989
- Clinical Uses of Intravenous Anesthetic and Analgesic InfusionsAnesthesia & Analgesia, 1989